February 1, 2000
Journal Article

Pretargeted radioimmunotherapy (PRIT (TM)) for treatment of non-Hodgkin's lymphoma (NHL): Initial phase I/II study results

Abstract

There is no abstract currently available for this item

Revised: September 12, 2002 | Published: February 1, 2000

Citation

Weiden P.L., H.B. Breitz, O. Press, J.W. Appelbaum, J.K. Bryan, S. Gaffigan, and D. Stone, et al. 2000. Pretargeted radioimmunotherapy (PRIT (TM)) for treatment of non-Hodgkin's lymphoma (NHL): Initial phase I/II study results. Cancer Biotherapy & Radiopharmaceuticals 15, no. 1:15-29. PNNL-SA-31608.